Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment.

Source:http://linkedlifedata.com/resource/pubmed/id/9403047

Download in:

View as

General Info

PMID
9403047